Dexpemedolac

N/A

Report date: 2022/01/25 17:31:02
NME

Base Information

Drug NameDexpemedolac
Drug Alias Name培美酸pemedolacopemedolacum右培美酸Pemedolac +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPainRheumatic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsPainRheumatic Diseases

Other Information

ATC CodeN/A
Related LinksKEGG